MWNA
ENZ

Marshall Wace North America’s Enzo Biochem, Inc. ENZ Stock Holding History

Marshall Wace North America’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-29,947
Closed -$164K – 1752
2018
Q1 		$164K Sell
29,947
-99,428
-77% -$700K ﹤0.01% 1350
2017
Q4 		$1.05M Buy
+129,375
New +$1.24M 0.01% 984
2017
Q3 		– Sell
-76,375
Closed -$840K – 1546
2017
Q2 		$840K Buy
76,375
+46,943
+159% +$437K 0.01% 985
2017
Q1 		$235K Buy
+29,432
New +$207K ﹤0.01% 902

Other funds holding ENZ

EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Marshall Wace North America's ENZ Position: Q2 2018 in Review

Marshall Wace North America sold out of Enzo Biochem, Inc. (ENZ) in Q2 2018, closing a stake of 29,947 shares — an estimated $164K sold.

Marshall Wace North America first reported a position in ENZ in Q1 2017 and held it in 4 quarters. The position peaked at $1.05M in Q4 2017. 97 funds tracked by Wall St. Rank hold ENZ as of Q2 2018.

  • Marshall Wace North America reported no remaining Enzo Biochem, Inc. position as of Q2 2018 after selling out during the quarter.
  • Marshall Wace North America sold 29,947 Enzo Biochem, Inc. shares in Q2 2018, an estimated $164K.
  • Marshall Wace North America first reported a position in Enzo Biochem, Inc. in Q1 2017 and held it in 4 quarters.
  • Marshall Wace North America's Enzo Biochem, Inc. position peaked at $1.05M in Q4 2017.
  • 97 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2018.

Based on Marshall Wace North America's 13F filing for Q2 2018, filed 14 Aug 2018.